N. V. Lomakin

1.4k total citations
29 papers, 126 citations indexed

About

N. V. Lomakin is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Internal Medicine. According to data from OpenAlex, N. V. Lomakin has authored 29 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 8 papers in Infectious Diseases and 7 papers in Internal Medicine. Recurrent topics in N. V. Lomakin's work include Antiplatelet Therapy and Cardiovascular Diseases (14 papers), COVID-19 Clinical Research Studies (8 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). N. V. Lomakin is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (14 papers), COVID-19 Clinical Research Studies (8 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). N. V. Lomakin collaborates with scholars based in Russia, United States and Poland. N. V. Lomakin's co-authors include Arthur M. Melkumyants, O. A. Antonova, Anatoly V. Kubyshkin, Victor L. Serebruany, И. И. Фомочкина, Д. Н. Проценко, Daria Fomina, О. М. Моисеева, Mikhail Gilyarov and Е. А. Smolyarchuk and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and Annals of the Rheumatic Diseases.

In The Last Decade

N. V. Lomakin

19 papers receiving 113 citations

Peers

N. V. Lomakin
Atefeh Abedini Iran
Alexander Guðjónsson Iceland
Jonas Bovijn United Kingdom
Meera Marji United States
Marina Izak Israel
Artemis Papadaki United Kingdom
Jinyu Zhang China
Razi Alalqam Ireland
Marcus V. Agrela Brazil
Xiaokai Feng China
Atefeh Abedini Iran
N. V. Lomakin
Citations per year, relative to N. V. Lomakin N. V. Lomakin (= 1×) peers Atefeh Abedini

Countries citing papers authored by N. V. Lomakin

Since Specialization
Citations

This map shows the geographic impact of N. V. Lomakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. V. Lomakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. V. Lomakin more than expected).

Fields of papers citing papers by N. V. Lomakin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. V. Lomakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. V. Lomakin. The network helps show where N. V. Lomakin may publish in the future.

Co-authorship network of co-authors of N. V. Lomakin

This figure shows the co-authorship network connecting the top 25 collaborators of N. V. Lomakin. A scholar is included among the top collaborators of N. V. Lomakin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. V. Lomakin. N. V. Lomakin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lomakin, N. V., et al.. (2025). Comparative clinical and laboratory study of rivaroxaban and its generic forms in patients with stable coronary artery disease. Russian Journal of Cardiology. 30(2). 6286–6286.
2.
Солопова, А. Г., et al.. (2025). Recurrent thrombosis in malignant neoplasms: clinical significance of long-term anticoagulant prophylaxis. Obstetrics Gynecology and Reproduction. 19(2). 168–179.
3.
4.
Lebedev, Georgy, et al.. (2024). Experience of using Beers criteria in clinical practice (according to Russian literature). SHILAP Revista de lepidopterología. 17(3). 384–395.
5.
Драпкина, О. М., Т. В. Вавилова, Karpov IuA, et al.. (2023). The resolution of the Expert Council on current issues of the use of acetylsalicylic acid for the purpose of primary prevention of cardiovascular diseases in the light of new scientific data and updated clinical guidelines. CARDIOVASCULAR THERAPY AND PREVENTION. 21(12). 3487–3487. 2 indexed citations
6.
Melkumyants, Arthur M., et al.. (2022). Effect of Sulodexide on Circulating Blood Cells in Patients with Mild COVID-19. Journal of Clinical Medicine. 11(7). 1995–1995. 5 indexed citations
7.
Lomakin, N. V., Д. Н. Проценко, Mazurov Vi, et al.. (2021). The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study. Inflammation Research. 70(10-12). 1233–1246. 35 indexed citations
8.
Melkumyants, Arthur M., et al.. (2021). Injury of vascular endothelium and erythrocytes in COVID-19 patients. Consilium Medicum. 23(6). 469–476. 8 indexed citations
9.
10.
Melkumyants, Arthur M., et al.. (2021). Mild COVID-19 and Impaired Blood Cell–Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics?. Thrombosis and Haemostasis. 122(1). 123–130. 15 indexed citations
11.
12.
Lomakin, N. V., et al.. (2019). Acute Coronary Syndrome Registry of High Risk Patients: 30-Day Outcome. Kardiologiia. 59(11). 14–20. 1 indexed citations
13.
Lomakin, N. V., et al.. (2019). Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding. SHILAP Revista de lepidopterología. 14(6). 944–950. 1 indexed citations
14.
15.
Lomakin, N. V., et al.. (2019). Evgeny Chazov: first thrombolysis for ischaemic stroke. European Heart Journal. 40(28). 2281–2283.
16.
Lomakin, N. V., et al.. (2019). Thrombocytopenia and prospective endovascular intervention in a patient with coronary artery disease. SHILAP Revista de lepidopterología. 16–21. 1 indexed citations
17.
Li, Jiaxin, Moo Hyun Kim, Eun‐Seok Shin, et al.. (2018). Impact of CYP2C19 Polymorphism on Antiplatelet Potency of Prasugrel 5 and 10 mg Daily Maintenance. Cardiology. 140(3). 155–162. 1 indexed citations
18.
Kubyshkin, Anatoly V., et al.. (2016). Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia. Inflammation Research. 65(10). 785–794. 37 indexed citations
19.
Lomakin, N. V., et al.. (2013). Historical overview of studies on inflammation in Russia. Inflammation Research. 62(5). 441–450. 4 indexed citations
20.
Lomakin, N. V., et al.. (2011). [Cyclooxygenase inhibitors and antiplatelet effect of acetylsalicylic acid. selective approach to nonsteroidal anti-inflammatory drugs in cardiological practice].. PubMed. 51(7). 47–52.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atefeh Abedini Breakdown of academic impact, for papers by Alexander Guðjónsson Breakdown of academic impact, for papers by Jonas Bovijn Breakdown of academic impact, for papers by Meera Marji Breakdown of academic impact, for papers by Marina Izak Breakdown of academic impact, for papers by Artemis Papadaki Breakdown of academic impact, for papers by Jinyu Zhang Breakdown of academic impact, for papers by Razi Alalqam Breakdown of academic impact, for papers by Marcus V. Agrela Breakdown of academic impact, for papers by Xiaokai Feng
Rankless by CCL
2026